Get the Stockscreener App
3.54
1.43%
0.05
After Hours:
3.60
0.06
+1.69%
Clene Inc stock is traded at $3.54, with a volume of 63,289.
It is up +1.43% in the last 24 hours and down -9.46% over the past month.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
See More
Previous Close:
$3.49
Open:
$3.51
24h Volume:
63,289
Relative Volume:
0.74
Market Cap:
$29.27M
Revenue:
$442.00K
Net Income/Loss:
$-30.46M
P/E Ratio:
-0.7937
EPS:
-4.46
Net Cash Flow:
$-27.47M
1W Performance:
-3.28%
1M Performance:
-9.46%
6M Performance:
-21.16%
1Y Performance:
-22.20%
1-Day Range:
$3.50
$3.57
1-Week Range:
$3.25
$3.9292
52-Week Range:
$2.2801
$6.96
Clene Inc Stock (CLNN) Company Profile
Name
Clene Inc
Sector
Industry
Phone
801-676-9695
Address
6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY
Compare CLNN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLNN
Clene Inc
|
3.54 | 31.35M | 442.00K | -30.46M | -27.47M | -4.46 |
|
KHC
Kraft Heinz Co
|
27.46 | 33.72B | 25.43B | 2.66B | 3.03B | 2.19 |
|
JBS
Jbs N V
|
13.80 | 29.72B | 88.95B | 2.16B | 374.50M | 0.9748 |
|
K
Kellanova
|
79.83 | 27.69B | 12.63B | 1.38B | 863.00M | 3.96 |
|
GIS
General Mills Inc
|
48.98 | 26.69B | 19.64B | 2.56B | 2.48B | 4.55 |
|
MKC
Mccormick Co Inc
|
70.63 | 19.16B | 6.68B | 792.60M | 774.40M | 2.94 |
Clene Inc Stock (CLNN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-04-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Jul-18-22 | Initiated | H.C. Wainwright | Buy |
| May-02-22 | Initiated | Canaccord Genuity | Buy |
| Sep-28-21 | Initiated | Oppenheimer | Outperform |
Clene Inc Stock (CLNN) Latest News
What catalysts could drive Clene Inc. Equity Warrant stock higher in 2025Pre Market Picks With High Returns - jammulinksnews.com
Statistical indicators supporting Clene Inc. Equity Warrant’s strengthHigh Yield Stock Screening Results Explained - metal.it
Order Book Volume Tilts Bullish on Clene Inc. Equity WarrantAccurate Technical Trend Reversal Picks Detected - metal.it
Clene Inc. Advances Toward FDA Approval for ALS Treatment CNM-Au8® - citybuzz -
Clene Inc. Reaches Critical Trendline SupportHigh Growth Low Risk Stock Selection Gets Analyst Nod - metal.it
How many analysts rate Clene Inc. as a “Buy”Turn market volatility into profit opportunities - jammulinksnews.com
What are the technical indicators suggesting about Clene Inc. Equity WarrantTrack top-performing stocks in real-time - jammulinksnews.com
What are analysts’ price targets for Clene Inc. Equity Warrant in the next 12 monthsUnlock market-leading stock analysis - jammulinksnews.com
What is the risk reward ratio of investing in Clene Inc. Equity Warrant stockAccess powerful market insights for free - jammulinksnews.com
Does Clene Inc. Equity Warrant stock perform well during market downturnsMassive portfolio appreciation - jammulinksnews.com
Is Clene Inc. a growth stock or a value stockHigh-impact stock picks - jammulinksnews.com
What is Clene Inc. Equity Warrant company’s growth strategyOutstanding trading profits - jammulinksnews.com
How volatile is Clene Inc. Equity Warrant stock compared to the marketRetirement Planning Data Feed That Work - jammulinksnews.com
What markets is Clene Inc. expanding into Is MURA stock a good long term investment optionBuild wealth steadily with proven investment techniques - jammulinksnews.com
Is Clene Inc. Equity Warrant a growth stock or a value stockCapitalize on market trends with expert guidance - jammulinksnews.com
How does Clene Inc. Equity Warrant compare to its industry peersExceptional growth trajectory - jammulinksnews.com
Is it the right time to buy Clene Inc. stockAchieve consistent profits with proven methods - jammulinksnews.com
When is Clene Inc. Equity Warrant stock expected to show significant growthCapital growth strategies that work - jammulinksnews.com
How does Clene Inc. generate profit in a changing economyUnlock powerful market trend analysis - jammulinksnews.com
What are Clene Inc. company’s key revenue driversHigh-impact stock picks - jammulinksnews.com
What makes Clene Inc. Equity Warrant stock price move sharplyBuild a diversified portfolio for sustainable growth - jammulinksnews.com
What are Clene Inc. Equity Warrant company’s key revenue driversFree Capital Allocation Plans - jammulinksnews.com
Why Clene Inc. Equity Warrant stock attracts strong analyst attentionShort Term Profit Focus - metal.it
What drives Clene Inc. stock priceFree Market Volatility Navigation Tips - PrintWeekIndia
What analysts say about Clene Inc. stockFree Wealth Planning Blueprint - PrintWeekIndia
Is Clene Inc. Equity Warrant stock a growth or value playTriple-digit profit margins - jammulinksnews.com
Can Clene Inc. Equity Warrant stock recover from recent declineOutstanding trading profits - jammulinksnews.com
How high can Clene Inc. stock price go in 2025Rapidly growing investment returns - jammulinksnews.com
Is Clene Inc. Equity Warrant a good long term investmentSkyrocketing profit margins - Autocar Professional
Clene Inc. Advances Neurodegenerative Disease Treatment with FDA-Backed Biomarker Analysis - citybuzz -
Does Clene Inc. Equity Warrant stock pay reliable dividendsTriple-digit returns - jammulinksnews.com
Will Clene Inc. Equity Warrant stock benefit from AI tech trendsUnstoppable investment returns - jammulinksnews.com
Clene to Present at the Jones Healthcare and Technology Innovation Conference - The Globe and Mail
What drives Clene Inc. Equity Warrant stock priceBreakthrough financial growth - jammulinksnews.com
Clene Inc. Equity Warrant Stock Analysis and ForecastFree Trading Psychology Coaching - jammulinksnews.com
Clene Inc Stock (CLNN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):